Reversible cerebral vasoconstriction syndrome: A review of pathogenesis, clinical presentation, and treatment

被引:13
|
作者
Singhal, Aneesh B. [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Neurol Dept, Boston, MA USA
[2] Massachusetts Gen Hosp, Neurol Dept, Boston, MA 02114 USA
关键词
Thunderclap headache; cerebral vasoconstriction; arteriopathy; LONG-TERM OUTCOMES; THUNDERCLAP HEADACHE; PRIMARY ANGIITIS; SUBARACHNOID HEMORRHAGE; HYPERINTENSE VESSELS; ANGIOPATHY; VASCULITIS; PATHOPHYSIOLOGY; ANGIOGRAPHY; FEATURES;
D O I
10.1177/17474930231181250
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Reversible segmental narrowing of the intracranial arteries has been described since several decades in numerous clinical settings, using variable nosology. Twenty-one years ago, we tentatively proposed the unifying concept that these entities, based on similar clinical-imaging features, represented a single cerebrovascular syndrome. This "reversible cerebral vasoconstriction syndrome" or RCVS has now come of age. A new International Classification of Diseases code, (ICD-10, I67.841) has been established, enabling larger-scale studies. The RCVS2 scoring system provides high accuracy in confirming RCVS diagnosis and excluding mimics such as primary angiitis of the central nervous system. Several groups have characterized its clinical-imaging features. RCVS predominantly affects women. Recurrent worst-ever (thunderclap) headaches are typical at onset. While initial brain imaging is often normal, approximately one-third to half develop complications such as convexity subarachnoid hemorrhages, lobar hemorrhages, ischemic strokes located in arterial "watershed" territories and reversible edema, alone or in combination. Vasoconstriction evolves over hours to days, first affecting distal and then the more proximal arteries. An overlap between RCVS and primary thunderclap headache, posterior reversible encephalopathy syndrome, Takotsubo cardiomyopathy, transient global amnesia, and other conditions has been recognized. The pathophysiology remains largely unknown. Management is mostly symptomatic: headache relief with analgesics and oral calcium-channel blockers, removal of vasoconstrictive factors, and avoidance of glucocorticoids that can significantly worsen outcome. Intra-arterial vasodilator infusions provide variable success. Overall, 90-95% of admitted patients achieve complete or major resolution of symptoms and clinical deficits within days to weeks. Recurrence is exceptional, although 5% can later develop isolated thunderclap headaches with or without mild cerebral vasoconstriction.
引用
收藏
页码:1151 / 1160
页数:10
相关论文
共 50 条
  • [1] Reversible Cerebral Vasoconstriction Syndrome: A Diagnostic Imaging Review
    Burton, Tina M.
    Bushnell, Cheryl D.
    STROKE, 2019, 50 (08) : 2253 - 2258
  • [2] Reversible Cerebral Vasoconstriction Syndrome for the Internist-A Narrative Review
    Edlow, Jonathan A.
    Baggett, Meridale
    Singhal, Aneesh
    AMERICAN JOURNAL OF MEDICINE, 2025, 138 (03) : 396 - 405
  • [3] Verapamil in the treatment of reversible cerebral vasoconstriction syndrome: A systematic review
    Collins, Luke
    Lam, Lydia
    Kleinig, Oliver
    Proudman, William
    Zhang, Ruyi
    Bagster, Michelle
    Kovoor, Joshua
    Gupta, Aashray
    Goh, Rudy
    Bacchi, Stephen
    Schultz, David
    Kleinig, Timothy
    JOURNAL OF CLINICAL NEUROSCIENCE, 2023, 113 : 130 - 141
  • [4] Reversible Cerebral Vasoconstriction Syndrome, Part 1: Epidemiology, Pathogenesis, and Clinical Course
    Miller, T. R.
    Shivashankar, R.
    Mossa-Basha, M.
    Gandhi, D.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2015, 36 (08) : 1392 - 1399
  • [5] Reversible cerebral vasoconstriction syndrome: review of neuroimaging findings
    Perillo, Teresa
    Paolella, Chiara
    Perrotta, Giulia
    Serino, Antonietta
    Caranci, Ferdinando
    Manto, Andrea
    RADIOLOGIA MEDICA, 2022, 127 (09): : 981 - 990
  • [6] Treatment-Related Reversible Cerebral Vasoconstriction Syndrome
    Avola, Giulia
    Pezzini, Alessandro
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (19)
  • [7] Reversible cerebral vasoconstriction syndrome
    Neel, A.
    Guillon, B.
    Auffray-Calvier, E.
    Hello, M.
    Hamidou, M.
    REVUE DE MEDECINE INTERNE, 2012, 33 (10): : 586 - 592
  • [8] Reversible Cerebral Vasoconstriction Syndrome: Recognition and Treatment
    Cappelen-Smith, Cecilia
    Calic, Zeljka
    Cordato, Dennis
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2017, 19 (06)
  • [9] Fatal reversible cerebral vasoconstriction syndrome
    Kunchok, Amy
    Castley, Helen C.
    Aldous, Lucie
    Hawke, Simon H.
    Torzillo, Emma
    Parker, Geoffrey D.
    Halmagyi, G. Michael
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2018, 385 : 146 - 150
  • [10] Reversible cerebral vasoconstriction syndrome
    Calic, Z.
    Cappelen-Smith, C.
    Zagami, A. S.
    INTERNAL MEDICINE JOURNAL, 2015, 45 (06) : 599 - 608